UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
AMENDMENT NO. 2
on
FORM 8-K/A
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of Earliest Event Reported): January 24, 2000
XOMA LTD.
- --------------------------------------------------------------------------------
(Exact name of registrant as specified in its charter)
BERMUDA
- --------------------------------------------------------------------------------
(State or other jurisdiction of incorporation)
0-14710 52-2154066
- ------------------------------- ------------------------------
(Commission File Number) (IRS Employer Identification No.)
2910 Seventh Street, Berkeley, California 94710
- --------------------------------------------------------------------------------
(Address of principal executive offices) (Zip code)
Registrant's telephone number, including area code (510) 644-1170
------------------------------
- --------------------------------------------------------------------------------
(Former name or former address, if changed since last report)
Item 7. Exhibits
1. Press Release dated January 24, 2000.*
2. License Agreement dated as of January 25, 2000 between XOMA Ireland Limited
and Baxter Healthcare Corporation (with certain confidential information
omitted, which omitted information is the subject of a confidential
treatment request and has been filed separately with the Securities and
Exchange Commission).
3. Supply and Development Agreement dated as of January 25, 2000 between XOMA
(US) LLC and Baxter Healthcare Corporation (with certain confidential
information omitted, which omitted information is the subject of a
confidential treatment request and has been filed separately with the
Securities and Exchange Commission).
- ------------
* Previously filed
-2-
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
Dated: March 9, 2000 XOMA LTD.
By: /s/ Christopher J. Margolin
----------------------------------
Christopher J. Margolin
Vice President, General
Counsel and Secretary
EXHIBIT INDEX
Number Description
1. Press Release dated January 24, 2000*
2. License Agreement dated as of January 25, 2000 between XOMA Ireland Limited
and Baxter Healthcare Corporation (with certain confidential information
omitted, which omitted information is the subject of a confidential
treatment request and has been filed separately with the Securities and
Exchange Commission).
3. Supply and Development Agreement dated as of January 25, 2000 between XOMA
(US) LLC and Baxter Healthcare Corporation (with certain confidential
information omitted, which omitted information is the subject of a
confidential treatment request and has been filed separately with the
Securities and Exchange Commission).
- ------------
* Previously filed